2 results match your criteria: "Oklahoma University Bioengineering Center[Affiliation]"
Free Radic Biol Med
January 2008
Oklahoma University Bioengineering Center, Norman, OK, USA.
The prognosis of patients who are diagnosed with glioblastoma multiforme is very poor, due to the difficulty of an early and accurate diagnosis and the lack of currently efficient therapeutic compounds. The efficacy of phenyl-tert-butylnitrone (PBN) as a potential anti-glioma therapeutic drug was assessed by magnetic resonance (MR) imaging (T(1)/T(2)-weighted imaging) and MR angiography (time-of-flight imaging, in conjunction with a Mathematica-based program) methods by monitoring morphologic properties, growth patterns, and angiogenic behaviors of a moderately aggressive rat C6 glioma model. MR results from untreated rats showed the diffusive invasiveness of C6 gliomas, with some associated angiogenesis.
View Article and Find Full Text PDFAdv Exp Med Biol
March 2007
Oklahoma University Bioengineering Center, The University of Oklahoma, Norman, OK 73019, USA.
Muskuloskeletal tissue includes bone, cartilage, ligament, skeletal muscle and tendons. These tissues malfunction either due to a natural injury, trauma, or a disorder. In all cases natural regeneration needs to be enhanced by medication and, in many instances, by surgery.
View Article and Find Full Text PDF